[go: up one dir, main page]

BRPI0816256A2 - Uso de hidrofobina, e, processo para a preparação de um agente para a absorção melhorada de substâncias ativas no uso tópico - Google Patents

Uso de hidrofobina, e, processo para a preparação de um agente para a absorção melhorada de substâncias ativas no uso tópico

Info

Publication number
BRPI0816256A2
BRPI0816256A2 BRPI0816256A BRPI0816256A2 BR PI0816256 A2 BRPI0816256 A2 BR PI0816256A2 BR PI0816256 A BRPI0816256 A BR PI0816256A BR PI0816256 A2 BRPI0816256 A2 BR PI0816256A2
Authority
BR
Brazil
Prior art keywords
hydrophobin
preparing
agent
active substances
improved absorption
Prior art date
Application number
Other languages
English (en)
Inventor
Marvin Karos
Claus Bollschweiler
Thomas Subkowski
Heiko Barg
Original Assignee
Basf Se
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Se filed Critical Basf Se
Publication of BRPI0816256A2 publication Critical patent/BRPI0816256A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Dentistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Inorganic Chemistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Birds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BRPI0816256 2007-09-13 2008-08-20 Uso de hidrofobina, e, processo para a preparação de um agente para a absorção melhorada de substâncias ativas no uso tópico BRPI0816256A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP07116363 2007-09-13
EP07121650 2007-11-27
PCT/EP2008/060870 WO2009037061A2 (de) 2007-09-13 2008-08-20 Verwendung von hydrophobin-polypeptiden als penetrationsverstärker

Publications (1)

Publication Number Publication Date
BRPI0816256A2 true BRPI0816256A2 (pt) 2015-03-17

Family

ID=39769569

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0816256 BRPI0816256A2 (pt) 2007-09-13 2008-08-20 Uso de hidrofobina, e, processo para a preparação de um agente para a absorção melhorada de substâncias ativas no uso tópico

Country Status (8)

Country Link
US (1) US20100240774A1 (pt)
EP (2) EP2676680A1 (pt)
JP (1) JP2010539125A (pt)
CN (1) CN101842118B (pt)
BR (1) BRPI0816256A2 (pt)
CA (1) CA2698293A1 (pt)
RU (2) RU2491096C9 (pt)
WO (1) WO2009037061A2 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2007012021A (es) * 2005-03-31 2008-03-14 Basf Ag El uso de polipeptidos como promotores de adhesion.
DE102005033002A1 (de) * 2005-07-14 2007-01-18 Basf Ag Wässrige Monomeremulsionen enthaltend Hydrophobin
WO2010020587A2 (de) * 2008-08-18 2010-02-25 Basf Se Verwendung von hydrophobin bei der nicht-permanenten färbung von keratin
WO2010060702A1 (en) * 2008-11-03 2010-06-03 Basf Se Photoinitiator mixtures
AU2009319183B2 (en) 2008-11-27 2014-06-05 B.R.A.I.N. Biotechnology Research And Information Network Ag Hydrophobins as surface active proteins as excipients in solid pharmaceutical formulations
US8758730B2 (en) 2009-02-26 2014-06-24 B.R.A.I.N. Biotechnology Research And Information Network Ag Compositions, use and method for the use of surface active proteins in topical drug delivery across keratin
CA2752808A1 (en) * 2009-03-09 2010-09-16 Basf Se Use of a synergistic mixture of water-soluble polymers and hydrophobins for thickening aqueous phases
US8357382B1 (en) * 2009-04-02 2013-01-22 Hilt Bethany L Cosmetic formulations
FI20095638A0 (fi) * 2009-06-09 2009-06-09 Valtion Teknillinen Hydrofobiineja aktiivisten aineiden dispergointiin
EP2371844A1 (en) 2010-03-25 2011-10-05 B.R.A.I.N. Biotechnology Research and Information Network AG Chimeric surface active proteins
WO2011101457A1 (en) 2010-02-18 2011-08-25 B.R.A.I.N. Biotechnology Research And Information Network Ag Chimeric surface active proteins
US8563031B2 (en) * 2010-05-27 2013-10-22 Absize, Inc. Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith
CN103209671A (zh) * 2010-08-12 2013-07-17 荷兰联合利华有限公司 口腔护理组合物
US8658680B2 (en) * 2010-08-17 2014-02-25 Bayer Cropscience Lp Chemically stable dispersions of prothioconazole and processes for preparing them
US20160250298A1 (en) * 2013-11-01 2016-09-01 Spherium Biomed S.L. Inclusion bodies for transdermal delivery of therapeutic and cosmetic agents
UA119797C2 (uk) * 2014-11-05 2019-08-12 Басф Се Спосіб одержання агрохімічної композиції зі зниженою токсичністю шляхом подрібнювання попередньо приготовленої суміші пестициду й гідрофобіну
KR101786914B1 (ko) * 2017-01-31 2017-11-15 주식회사 삼양사 피부 리프팅 또는 탄력 개선을 위한 점착성 탄력 밴드
RU2751507C1 (ru) * 2018-01-10 2021-07-14 Джи2Джибио, Инк. Поликапролактоновый микросферный филлер, содержащий витамин с, и способ его изготовления
CN108530106A (zh) * 2018-06-14 2018-09-14 长沙鹏登生物陶瓷有限公司 一种制备渐变色氧化锆义齿陶瓷坯体的染色液
CN108585845A (zh) * 2018-06-14 2018-09-28 长沙鹏登生物陶瓷有限公司 一种颜色和透性渐变氧化锆义齿陶瓷坯体的制备方法
JP2022537710A (ja) * 2019-06-15 2022-08-29 バイエル・アクチエンゲゼルシヤフト 安定化ジチオカルバメート製剤
EP4013418A4 (en) * 2019-08-14 2023-07-19 Nanometics LLC (D.B.A. Phd Biosciences) DERMAL PHARMACEUTICAL FORMULATION OF URACIL
CN111842088B (zh) * 2020-07-30 2021-08-10 齐鲁工业大学 一种低电位疏水性多肽单层膜及其制备方法与应用

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1165574B (de) 1960-08-08 1964-03-19 Dehydag Gmbh Verfahren zur Herstellung von als Emulgiermittel fuer Salbengrundlagen dienenden Mischestern
ES2089056T3 (es) 1990-06-16 1996-10-01 Nihon Nohyaku Co Ltd Derivados de hidrazincarboxamida, un procedimiento para la produccion de los mismos, y usos de los mismos.
DE4210165A1 (de) 1991-07-30 1993-02-04 Schering Ag Transdermale therapeutische systeme
AU5914196A (en) * 1995-06-12 1997-01-09 Proefstation Voor De Champignoncultuur Hydrophobins from edible fungi, genes, nucleotide sequences and dna-fragments encoding for said hydrophobins, and expression thereof
DE19626762A1 (de) 1996-07-03 1998-01-08 Basf Ag Enzymatisch spaltbare Linker für Festphasensynthesen
TW460476B (en) 1997-04-14 2001-10-21 American Cyanamid Co Fungicidal trifluoromethylalkylamino-triazolopyrimidines
ES2172864T3 (es) 1997-08-20 2002-10-01 Basf Ag 2-metoxibenzofenonas fungicidas.
WO1999041255A1 (en) 1998-02-11 1999-08-19 American Cyanamid Company Fungicidal 7-alkyl-triazolopyrimidines
JP4570787B2 (ja) * 1999-03-25 2010-10-27 バルティオン テクニリーネン トゥトキムスケスクス タンパク質を分離する方法
GB0002663D0 (en) 2000-02-04 2000-03-29 Biomade B V Method of stabalizing a hydrophobin-containing solution and a method of coating a surface with a hydrophobin
EP1399296A2 (en) 2001-06-25 2004-03-24 Fast Technology GmbH Power torque tool
EP1406903B1 (de) 2001-07-05 2007-02-14 Basf Aktiengesellschaft Fungizide triazolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel
FR2833490B1 (fr) 2001-12-14 2004-12-10 Oreal Utilisition cosmetique d'au moins une hydrophobine pour le traitement des matieres keratiniques et compositions mises en oeuvre
PL211515B1 (pl) 2002-03-11 2012-05-31 Basf Ag Sposób uodporniania roślin na bakteriozy i zastosowanie pochodnych benzenu do uodporniania roślin
EP1815846A3 (en) * 2002-10-11 2008-10-22 Idea Ag Aggregate with increased deformability, comprising at least three amphipats, for improved transport through semi-permeable barriers and for the non-invasive drug application in vivo, especially through the skin
US7241734B2 (en) 2004-08-18 2007-07-10 E. I. Du Pont De Nemours And Company Thermophilic hydrophobin proteins and applications for surface modification
EP1848733B1 (de) * 2005-02-07 2017-06-21 Basf Se Neue hydrophobinfusionsproteine, deren herstellung und verwendung
TW200639179A (en) 2005-02-07 2006-11-16 Basf Ag Method for coating surfaces with hydrophobins
DE502006007963D1 (de) * 2005-03-30 2010-11-11 Basf Se Verwendung von hydrophobinen zur schmutzabweisenden behandlung von harten oberflächen
EP1869138B1 (de) * 2005-04-01 2009-11-25 Basf Se Bohrspülung enthaltend hydrophobin
WO2006103251A1 (de) 2005-04-01 2006-10-05 Basf Aktiengesellschaft Verwendung von proteinen als demulgatoren
DE102005025969A1 (de) 2005-06-03 2006-12-28 Basf Ag Verfahren zur Verringerung der Verdunstungsgeschwindigkeit von Flüssigkeiten
CA2610785A1 (en) * 2005-06-06 2006-12-14 Basf Aktiengesellschaft Method for coating fibre substrate surfaces
DE102005027139A1 (de) 2005-06-10 2006-12-28 Basf Ag Neue Cystein-verarmte Hydrophobinfusionsproteine, deren Herstellung und Verwendung
DE102005029704A1 (de) * 2005-06-24 2007-01-11 Basf Ag Verwendung von Hydrophobin-Polypeptiden sowie Konjugaten aus Hydrophobin-Polypeptiden mit Wirk-oder Effektstoffen und ihre Herstellung sowie deren Einsatz in der Kosmetik
JP5105441B2 (ja) 2005-08-01 2012-12-26 ビーエーエスエフ ソシエタス・ヨーロピア 界面活性非酵素タンパク質の織布洗浄への利用
WO2010020587A2 (de) * 2008-08-18 2010-02-25 Basf Se Verwendung von hydrophobin bei der nicht-permanenten färbung von keratin

Also Published As

Publication number Publication date
US20100240774A1 (en) 2010-09-23
JP2010539125A (ja) 2010-12-16
CA2698293A1 (en) 2009-03-26
WO2009037061A3 (de) 2009-09-24
RU2013122925A (ru) 2014-11-27
RU2491096C2 (ru) 2013-08-27
RU2491096C9 (ru) 2014-02-10
EP2676680A1 (de) 2013-12-25
EP2200651A2 (de) 2010-06-30
CN101842118B (zh) 2012-08-08
WO2009037061A2 (de) 2009-03-26
RU2010114233A (ru) 2011-10-20
CN101842118A (zh) 2010-09-22

Similar Documents

Publication Publication Date Title
BRPI0816256A2 (pt) Uso de hidrofobina, e, processo para a preparação de um agente para a absorção melhorada de substâncias ativas no uso tópico
BRPI0906932A2 (pt) Gel hidrofílico estável, baseado em um polímero para aplicação tópica, processo para obeter o mesmo e uso do mesmo
BRPI0916630A2 (pt) composições para uso em construção e processo de aplicação das mesmas
BRPI0812521A2 (pt) Composto, composição farmacêutica, método para o tratamento de doença em um mamífero, processo para a preparação de um composto, e, uso de um composto
BRPI0908352A2 (pt) Processo para produzir estruturas porosas, estrutura porosa, e, uso da mesma
BRPI0920383A2 (pt) método para minimizar o diâmetro de uma solução de uréia, solução de uréia e uso de um tensoativo em solução de uréia
BRPI0812851A2 (pt) Composto, composição farmacêutica, métodos para o tratamento de uma doença e de uma condição em um indivíduo, processo para preparar um composto, e, uso de um composto
BRPI0920786A2 (pt) eletrodo frontal tendo superfície atacada quimicamente para uso em dispositivo fotovoltaico, e processo de produção do mesmo.
BRPI0611956A2 (pt) composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto
BRPI0914863A2 (pt) formulação tópica estável, e, uso da mesma
BR112013030042A2 (pt) composição em particular composição cosmética, processo para o tratamento cosmético não terapêutico das matérias queratínicas e uso de uma composição.
BRPI1006162A2 (pt) "composto,processo para preparar um composto,formulação farmacêutica,e uso de um composto".
BRPI0722053A2 (pt) método para o tratamento de câncer, formulação anticâncer, método de uso da formulação, e, uso de metoxiamina
BR112013003032A2 (pt) “corante, composição cosmética e processo cosmético para tratar matérias queratínicas”
BRPI0921995A2 (pt) processo de deslocamento de gás para água , e, uso de um adsorvente.
BRPI0919315A2 (pt) espelho, dispositivo, uso do espelho, e, processo de fabricacao de um espelho
BRPI0909354A2 (pt) processo para a produção de microcápsulas, microcápsula, formulação agroquímica, e, uso da mesma.
BRPI0822946A2 (pt) Derivado de carboxiamida, processo para preparação de derivado de carboxiamida, composição farmacêutica e uso do derivado de carboxiamida
BR112013004829A2 (pt) composição de agente de dispersão de produto químico agrícola, composição química agrícola, método para produzir um produto agrícola, método para aumentar eficácia em um produto químico agrícola, e uso da composição de agente de dispersão de produto químico agrícola.
BRPI0719523A2 (pt) Derivado de espirocetal de tioglicose e uso deste como agente terapêutico para diabetes
BR112013007567A2 (pt) processo para tratar fibras de queratina com o uso de pelo menos um agente redutor sulforoso, pelo menos um polímero catiônico e pelo menos um mercaptossiloxano
ECSP11010762A (es) Composición tópica para el tratamiento de queratosis actínica
BRPI0608802A2 (pt) composto, agente para combater fungos nocivos, processo para combater fungos nocivos fitopatogênicos, uso de compostos e, semente
BR112013014522A2 (pt) anticorpo anti-cd20 afucosilado e seu uso, composição e método para tratamento de um paciente que sofre de câncer
BRPI0813438A2 (pt) Processo para preparar um composto, uso de um composto, e, composto.

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2384 DE 13-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.